- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Cannabis Weekly Round-Up: Neptune Exits Cannabis Market
A cannabis producer in Canada is exiting the industry after struggling results.
Another cannabis producer has formally announced its exit strategy from the industry.
An association of mayors across the US have voiced their support of cannabis banking reform in the nation.
Keep reading to find out more cannabis highlights from the past five days.
Cannabis firm backs out of market to focus on ‘profits and growth’
The difficulty of justifying a cannabis business for Neptune Wellness Solutions (NASDAQ:NEPT,TSX:NEPT) got to be too much. On Wednesday (June 8), the Quebec-based firm confirmed a plan to divest from its cannabis business and let go of half its workforce.
The staff reduction will result in the firm saving C$5.8 million. The company plans to sell its cannabis brands, Mood Ring and PanHash, as well as its Sherbrooke, Quebec, facility, which it claims was recently appraised at C$21 million.
“This strategic divestiture greatly simplifies our overall structure, enabling us to hyper-focus on those areas of the business we believe are best positioned for profitability and growth," Michael Cammarata, president and CEO of Neptune, said in a statement.
Shares of Neptune have taken a hit following the announcement. In New York the company fell in value by over 15 percent since Wednesday’s trading session. The company opened on Friday (June 10) at a price point of US$0.12 per share.
US mayors want to see banking reform
A report from MJBizDaily indicated the US Conference of Mayors have now thrown their support behind cannabis banking reform by way of the SAFE Banking Act policy.
The association representing 1,400 cities passed a motion to support the long standing cannabis policy proposal.
They want Congress to pass the bill in order to “to provide financial security for cannabis dispensaries and related companies and enhance public safety.”
The SAFE Banking Act would change federal regulations so cannabis business would not fall outside federal rule.
Experts have told the Investing News Network (INN) this policy being adopted could open the doors to US operators listing in senior US exchanges and engaging with financiers that are currently barred from entering the space. There's also been chatter about how this policy would help clear investment strategies for the Canadian market.
Cannabis company news
- Tetra Bio-Pharma (TSX:TBP,OTCQB:TBPMF)launched an Australian subsidiary focused on clinical research trials in the country. “These are very exciting times for us as we continue to drive scientific excellence and deliver on the promise of cannabinoid-derived transformative medicines to improve patient health and quality of life," Tetra CEO Dr. Guy Chamberland said.
- Columbia Care (NEO:CCHW,CSE:CCHW,OTCQX:CCHWF)kicked off production in a new cultivation facility in New Jersey. Nicholas Vita, CEO of Columbia Care, said New Jersey “will serve as a model for those east coast states transitioning to adult use in the near term.”
- Tilray Brands (NASDAQ:TLRY,TSX:TLRY)launched a new medical oil product formulated to help with sleep issues. “We are pleased to add a dedicated night oil to the Aphria medical portfolio and broaden our offering of effective medical cannabis products to patients with a wider range of needs,” said Blair MacNeil, president of Tilray Canada.
- Ayr Wellness (CSE:AYR.A,OTCQX:AYRWF)obtained a license to sell adult-use products in its new dispensary in Greater Boston. The company expects to manage two dispensaries in the area.
Don't forget to follow us @INN_Cannabis for real-time updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.
The Beginner’s Guide to Investing in the Resource Sector
Ready to invest in the resource sector? Our beginner's guide makes it simple to get started.
Download your investing guide today.
Learn About Exciting Investing Opportunities in the Resource Sector
Your Newsletter Preferences
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.
Bryan is a Senior Editor with INN. After graduating from the Langara journalism program he did some freelance reporting with community newspapers in British Columbia. He initially wrote about the life science space for INN and now spends his time covering the marijuana market, from Canadian LPs to US-based companies, and the impact of this sector on investors.
Learn about our editorial policies.